Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Andrea Mogavero"'
Autor:
Alessio Rizzo, Ornella Cantale, Andrea Mogavero, Lucia Garetto, Manuela Racca, Tiziana Venesio, Shobana Anpalakhan, Silvia Novello, Vanesa Gregorc, Giuseppe Luigi Banna
Publikováno v:
Thoracic Cancer, Vol 14, Iss 24, Pp 2473-2483 (2023)
Abstract Background Inflammation in non‐small cell lung cancer (NSCLC) may impair the response to immune checkpoint inhibitors (ICIs) and can be indicated by peripheral blood inflammatory indexes. 2‐deoxy‐2‐[18F]fluoro‐D‐glucose positron
Externí odkaz:
https://doaj.org/article/6ea1188252e842478259d526a9596ccf
Autor:
Andrea Mogavero, Paolo Bironzo, Luisella Righi, Alessandra Merlini, Federica Benso, Silvia Novello, Francesco Passiglia
Publikováno v:
Life, Vol 13, Iss 6, p 1291 (2023)
Lung cancer is one of the most frequently diagnosed cancers worldwide and the leading cause of cancer-related death. The 2021 World Health Organization (WHO) classification provided a detailed and updated categorization of lung adenocarcinomas with a
Externí odkaz:
https://doaj.org/article/5e032ff010a34d279b3143bd255489e5
Autor:
Francesca Sangalli, Laura Ferrè, Ferdinando Clarelli, Andrea Mogavero, Vittorio Martinelli, Federica Esposito, Lucia Moiola, Bruno Colombo, Giancarlo Comi, Massimo Filippi
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 27(9)
Background: Fingolimod (FTY) is an effective second-line drug for relapsing-remitting multiple sclerosis, with ~50% patients showing no evidence of disease activity (NEDA) after 2 years. Nonetheless, the early identification of non-responders is extr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::564d2fcd9b917972b8dcbb2db4741109
https://pubmed.ncbi.nlm.nih.gov/32975468
https://pubmed.ncbi.nlm.nih.gov/32975468
Autor:
Giulia Manessi, Alberto Pisacane, Claudio Mossetti, Andrea Mogavero, Bruno Vincenzi, Enrico Ruffini, Delia Campanella, Sandra Aliberti, Alessandro Minelli, Alessandra Merlini, Raimondo Piana, Elena Maldi, Giovanni Grignani, Lorenzo D'Ambrosio, Maria Cristina Bruna, Tiziana Robba, Francesco Tolomeo
Publikováno v:
Journal of Clinical Oncology. 39:11571-11571
11571 Background: Despite surgically resectable pulmonary metastases may lead to cure patients with B-STS (Chudgar NP 2017), a substantial proportion of patients will eventually relapse. Presently, patient selection is based on unique organ involveme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20791352414b382ef6246028833499d6
https://doi.org/10.1200/jco.2021.39.15_suppl.11571
https://doi.org/10.1200/jco.2021.39.15_suppl.11571